Primary Site >> Pancreatic Cancer

Gene >> CCKAR

  • 2004
  • 2006
  • 2007
  • 2016
Ref: What are the pancreatic target cells for gastrin and its CCKB receptor? Is this a couple for cancerous cells?
PMID: 15448615
Ref: (99m)Tc-Tricarbonyl-K-H-K-H-cholecystokinin 8
PMID: 20641941
Ref: (68)Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
PMID: 22091478
Ref: (111)In/(68)Ga-Labeled DOTA-conjugated cyclo[gamma-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Asp-Phe-NH2 (cyclo-MG1), a minigastrin analog
PMID: 22787691
Ref: (111)In/(68)Ga-Labeled DOTA conjugated cyclo[gamma-d-Glu-Ala-Tyr-d-Lys]-Trp-Nle-Asp-Phe-NH2 (cyclo-MG2), a minigastrin analog
PMID: 22855967
Ref: (68)Ga-Labeled DOTA-conjugated sCCK8[Phe(2)(p-CH2SO3H),Nle(3,6)], a sulfated cholecystokinin 8 (sCCK8) peptide derivative
PMID: 23390663
Ref: (111)In-Labeled DOTA-conjugated sCCK8[Phe(2)(p-CH2SO3H),Nle(3,6)], a sulfated cholecystokinin 8 (sCCK8) peptide derivative
PMID: 23390667
Ref: Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant.
PMID: 15953675
Ref: Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.
PMID: 17613436
Ref: Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.
PMID: 17997137
Ref: Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.
PMID: 27072272